51 – 60 of 61
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Altered CSF Orexin and α-Synuclein Levels in Dementia Patients.
(
- Contribution to journal › Article
- 2011
-
Mark
Heredity in Parkinson's disease. From rare mutations to common genetic risk factors.
(
- Thesis › Doctoral thesis (compilation)
-
Mark
GDNF fails to exert neuroprotection in a rat {alpha}-synuclein model of Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Signs of Degeneration in 12-22-Year Old Grafts of Mesencephalic Dopamine Neurons in Patients with Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
A deadly spread: cellular mechanisms of α-synuclein transfer.
(
- Contribution to journal › Article
- 2010
-
Mark
Does A "Prion-Like" Mechanism Contribute to the Spreading of Neuropathology in Parkinson's Disease?
(
- Contribution to journal › Published meeting abstract
-
Mark
Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease.
(
- Contribution to journal › Article
- 2009
-
Mark
Suppression of Map Kinases Inhibits Microglial Activation and Attenuates Neuronal Cell Death Induced by Alpha-Synuclein Protofibrils
(
- Contribution to journal › Article
- 2008
-
Mark
The effect of alpha-synuclein knockdown on MPP plus toxicity in models of human neurons
(
- Contribution to journal › Article
- 2007
-
Mark
High dose levodopa therapy is not toxic in multiple system atrophy: Experimental evidence
(
- Contribution to journal › Article